Bio-Thera Solutions, Ltd.

¥17.77As of Sun 8 Nov 2026, 12:00 UTC
SSE:688177Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR (14.57%)
Div yield —
ROE (167.34%)
Biotechnology
Beta (5Y) 0.51
PE TTM —
TSR TTM (35.57%)
Mkt cap ¥7.358B
ROIC (72.49%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥23
29.75%
(79.58%)
Hold 7|12|5|11|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.38
0.42
0.45
0.44
19.85%
23.71%
29.29%
24.61%
Revenue¥M
663.6
662.1
685.6
691.1
1.88%
(0.34%)
1.78%
5.14%
Peers (US$1.103B)
Cap (US$)
PE
1.109B
18.76x
1.086B
26.50x
1.093B
12.92x
Capital
TTM
5Y
10Y
Leveragex
1.180
0.174
0.164
EBIT/Intx
0.891
0.552
0.533
Own earn%
512.55
63.15
9.10
Sh yield%
25.28
31.63
32.09
Owners
Insiders/Inst%
4.89
86.59
Short interest%
5.49
SBC / revenue%
0.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
8–11
$1 testx
−0.1
Incr. ROIC%
3